I am reporting unordered package, Michigan, USA
1 day ago •reported by user-cghc2873
Heather Fottys
646 S Walcott Ave
Chicago IL. 60609
1 year ago •source www.fda.gov
Recall notice
United States
Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens which are packaged in cartons of five pens to the consumer level. This product is not the branded Semglee® pen but the unbranded Insulin Glargine-yfgn pens. This batch is being recalled due to the potential for the label to be missing on some pens. This batch was manufactured by Biocon Sdn. Bhd. and was distributed by Mylan Specialty L.P. in the US between April 4, 2022 and May 5, 2022. To date, no adverse events related to this recall have been received for this product.1 day ago •reported by user-cghc2873
2 weeks ago •reported by user-vqqn8125
1 week ago •reported by user-jttn3275
2 weeks ago •reported by user-mrhd1868
4 weeks ago •reported by user-cpjky858
3 weeks ago •reported by user-mqqqh719
2 weeks ago •reported by user-bnjqx963
2 weeks ago •reported by user-hkzd6222
1 week ago •reported by user-xhdzb921
2 weeks ago •reported by user-vkvf9335
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Search